Advertisement

Deregulation of E-Cadherin in Precancerous Lesions and Gastric Cancer

  • Annie On On Chan
  • Benjamin Chun-Yu Wong

Introduction

Gastric cancer remains the second major cause of cancer-related deaths in the world. China and Hong Kong are among the high incidence areas in the world, showing no trend of reduction in gastric cancer incidence over the past 10 years and no improvement in the survival rate. Helicobacter pylori infection is an important etiologic risk factor in gastric cancer, and has been classified as a class I carcinogen by the World Health Organization. However, only a minority of the infected population eventually develop gastric cancer. Molecular studies of the host may give definite proof of the etiologic role of H. pylori in inducing gastric carcinoma.

E-cadherin is a transmembrane glycoprotein expressed on epithelial cells, and is responsible for homotypic cell adhesion. Defective cell adhesion may contribute to loss of contact inhibition of growth, which is an early step in carcinogenesis. The critical role of E-cadherin is underlined by the observation that familial gastric...

Keywords

Gastric Cancer Adenomatous Polyposis Coli Intestinal Metaplasia Bullous Pemphigoid Diffuse Gastric Cancer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, Baulida J, Garcia De Herreros A. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumor cells. Nat Cell Biol 2000; 2: 84–89.CrossRefPubMedGoogle Scholar
  2. Becker KF, Atkinson MJ, Reich U, Becker I, Nekarda H, Siewert JR, Hofler H. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 1994; 54: 3845–3852.PubMedGoogle Scholar
  3. Behrens J, Mareel MM, Van Roy FM, et al. Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J Cell Biol 1989; 108: 2435–2447.CrossRefPubMedGoogle Scholar
  4. Behrens J, Vakaet L, Friis R, Winterhager E, Van Roy F, Mareel MM, Birchmeier W. Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/beta-catenin complex in cells transformed with a temperature-sensitive v-SRC gene. J Cell Biol 1993; 120: 757–766.CrossRefPubMedGoogle Scholar
  5. Berx G, Becker KF, Hofler H, van Roy F. Mutations of the human E-cadherin (CDH1) gene. Hum Mutat 1998; 12: 226–237.CrossRefPubMedGoogle Scholar
  6. Berx G, Cleton-Jansen AM, Nollet F, de Leeuw WJ, van de Vijver M, Cornelisse C, van Roy F. E-cadherin is a invasion/invasion suppressor gene mutated in human lobular breast cancers. EMBO J 1995; 14: 6107–6115.PubMedGoogle Scholar
  7. Bienz M, Clevers H. Linking colorectal cancer to Wnt signaling. Cell 2000; 103: 311–320.CrossRefPubMedGoogle Scholar
  8. Birchmeier W, Behrens J. Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochem Biophys Acta 1994; 1198: 11–26.PubMedGoogle Scholar
  9. Bolós V, Peinado H, Pérez-Moreno MA, Fraga MF, Esteller M, Cano AJ. The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. J Cell Sci 2003; 116: 499–511.CrossRefPubMedGoogle Scholar
  10. Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, Portillo F, Nieto MA. The transcription factor snail controls epithelial—mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2000; 2: 76–83.CrossRefPubMedGoogle Scholar
  11. Chan AO, Chu KM, Huang C, Lam KF, Leung SY, Sun YW, Ko S, Xia HH, Cho CH, Hui WM, Lam SK, Rashid A. Association between Helicobacter pylori infection and interleukin 1beta polymorphism predispose to CpG island methylation in gastric cancer. Gut 2007; 56: 595–597.CrossRefPubMedGoogle Scholar
  12. Chan AO, Chu KM, Lam SK, Cheung KL, Law S, Kwok KF, Wong WM, Yuen MF, Wong BC. Early prediction of tumor recurrence after curative resection of gastric carcinoma by measuring soluble E-cadherin. Cancer 2005; 104: 740–746.CrossRefPubMedGoogle Scholar
  13. Chan AO, Chu KM, Lam SK, Wong BC, Kwok KF, Law S, Ko S, Hui WM, Yueng YH, Wong J. Soluble E-cadherin is an independent pretherapeutic factor for long-term survival in gastric cancer. J Clin Oncol 2003; 21: 2288–2293.CrossRefPubMedGoogle Scholar
  14. Chan AO, Huang C, Hui WM, Cho CH, Yuen MF, Lam SK, Rashid A, Wong BC. Stability of E-cadherin methylation status in gastric mucosa associated with histology changes. Aliment Pharmacol Ther 2006; 24: 831–836.CrossRefPubMedGoogle Scholar
  15. Chan AO, Lam SK, Chu KM, Lam CM, Kwok E, Leung SY, Yuen ST, Law SY, Hui WM, Lai KC, Wong CY, Hu HC, Lai CL, Wong J. Soluble E-cadherin is a valid prognostic marker in gastric carcinoma. Gut 2001; 48: 808–811.CrossRefPubMedGoogle Scholar
  16. Chan AO, Lam SK, Wong BC, Kwong YL, Rashid A. Gene methylation in non-neoplastic mucosa of gastric cancer: age or Helicobacter pylori related? Am J Pathol 2003; 163: 370–371.PubMedGoogle Scholar
  17. Chan AO, Lam SK, Wong BC, Wong WM, Yuen MF, Yeung YH, Hui WM, Rashid A, Kwong YL. Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer. Gut 2003; 52: 502–506.CrossRefPubMedGoogle Scholar
  18. Chan AO, Luk JM, Hui WM, Lam SK. Molecular biology of gastric carcinoma: from laboratory to bedside. J Gastroenterol Hepatol 1999; 14(12): 1150–1160.CrossRefPubMedGoogle Scholar
  19. Chan AO, Peng JZ, Lam SK, Lai KC, Yuen MF, Cheung HK, Kwong YL, Rashid A, Chan CK, Wong BC. Eradication of Helicobacter pylori infection reverses E-cadherin promoter hyper-methylation. Gut 2006; 55: 463–468.CrossRefPubMedGoogle Scholar
  20. Chan AO, Wong BC, Lan HY, Loke SL, Chan WK, Hui WM, Yuen YH, Ng I, Hou L, Wong WM, Yuen MF, Luk JM, Lam SK. Deregulation of E-cadherin-catenin complex in precancerous lesions of gastric adenocarcinoma. J Gastroenterol Hepatol 2003; 18: 534–539.CrossRefPubMedGoogle Scholar
  21. Chun YS, Lindor NM, Smyrk TC, Petersen BT, Burgart LJ, Guilford PJ, Donohue JH. Germline E-cadherin gene mutations: is prophylactic total gastrectomy indicated? Cancer 2001; 92: 181–187.CrossRefPubMedGoogle Scholar
  22. Comijn J, Berx G, Vermassen P, Verschueren K, van Grunsven L, Bruyneel E, Mareel M, Huylebroeck D, van Roy F. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell 2001; 7: 1267–1278.CrossRefPubMedGoogle Scholar
  23. Costello JF, Plass C. Methylation matters. J Med Genet 2001; 38: 285–303.CrossRefPubMedGoogle Scholar
  24. Damsky CH, Richa J, Solter D, Knudsen K, Buck CA. Identification and purification of a cell surface glycoprotein mediating intercellular adhesion in embryonic and adult tissue. Cell 1983; 34: 455–466.CrossRefPubMedGoogle Scholar
  25. Fujita Y, Krause G, Scheffner M, Zechner D, Leddy HE, Behrens J, Sommer T, Birchmeier W. Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex. Nat Cell Biol 2002; 4: 222–231.CrossRefPubMedGoogle Scholar
  26. Fujita K, Ohuchi N, Yao T, et al. Frequent overexpression, but not activation by point mutation, of ras genes in primary human gastric cancers. Gastroenterology 1987; 93: 1339–1345.PubMedGoogle Scholar
  27. Gabbert HE, Mueller W, Schneiders A, Meier S, Moll R, Birchmeier W, Hommel G. Prognostic value of E-cadherin expression in 413 gastric carcinomas. Int J Cancer 1996; 69: 184–189.CrossRefPubMedGoogle Scholar
  28. Gayther SA, Gorringe KL, Ramus SJ, et al. Identification of germ-line E-cadherin mutations in gastric cancer families of European origin. Cancer Res 1998; 58: 4086–4089.PubMedGoogle Scholar
  29. Giarelli E. Prophylactic gastrectomy for CDH1 mutation carriers. Clin J Oncol Nurs 2002; 6: 161–162.CrossRefPubMedGoogle Scholar
  30. Gofuku J, Shiozaki H, Doki Y, et al. Characterization of soluble E-cadherin as a disease marker in gastric cancer patients. Br J Cancer 1998; 78: 1095–1101.PubMedGoogle Scholar
  31. Grady WM, Willis J, Guilford PJ, et al. Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat Genet 2000; 26: 16–17.CrossRefPubMedGoogle Scholar
  32. Griffiths TR, Brotherick I, Bishop RI, et al. Cell adhesion molecules in bladder cancer: soluble serum E-cadherin correlates with predictors of recurrence. Br J Cancer 1996; 74: 579–584.PubMedGoogle Scholar
  33. Grooteclaes ML, Frisch SM. Evidence for a function of CtBP in epithelial gene regulation and anoikis. Oncogene 2000; 19: 3823–3828.CrossRefPubMedGoogle Scholar
  34. Grunwald G. The structural and functional analysis of cadherin calcium-dependent cell adhesion molecules. Curr Opin Cell Biol 1993; 5: 797–805.CrossRefPubMedGoogle Scholar
  35. Guilford PJ, Hopkins JBW, Grady WM, Markowitz SD, Willis J, Lynch H, Rajput A, Wiesner GL, Lindor NM, Burgart LJ, Toro TT, Lee D, Limacher JM, Shaw DW, Findlay MPN, Reeve AE. E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer. Hum Mutat 1999; 14: 249–255.CrossRefPubMedGoogle Scholar
  36. Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, Taite H, Scoular R, Miller A, Reeve AE. E-cadherin germline mutations in familial gastric cancer. Nature 1998; 392: 402–405.CrossRefPubMedGoogle Scholar
  37. Gumbiner BM. Regulation of cadherin adhesive activity. J Cell Biol 2000; 148: 399–404.CrossRefPubMedGoogle Scholar
  38. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996; 93: 9821–9826.CrossRefPubMedGoogle Scholar
  39. Humar B, Toro T, Graziano F, Muller H, Dobbie Z, Kwang-Yang H, Eng C, Hampel H, Gilbert D, Winship I, Parry S, Ward R, Findlay M, Christian A, Tucker M, Tucker K, Merriman T, Guilford P. Novel germline CDH1 mutations in hereditary diffuse gastric cancer families. Hum Mutat 2002; 19: 518–525.CrossRefPubMedGoogle Scholar
  40. Huntsman DG, Carneiro F, Lewis FR, MacLeod PM, Hayashi A, Monaghan KG, Maung R, Seruca R, Jackson CE, Caldas C. Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations. N Engl J Med 2001; 344: 1904–1909.CrossRefPubMedGoogle Scholar
  41. Juhasz M, Ebert MP, Schulz HU, Rocken C, Molnar B, Tulassay Z, Malfertheiner P. Dual role of serum soluble E-cadherin as a biological marker of metastatic development in gastric cancer. Scand J Gastroenterol 2003; 38: 850–855.CrossRefPubMedGoogle Scholar
  42. Kanai Y, Oda T, Tsuda H, Ochiai A, Hirohashi S. Point mutation of the E-cadherin gene in invasive lobular carcinoma of the breast. Jpn J Cancer Res 1994; 85: 1035–1039.PubMedGoogle Scholar
  43. Kang GH, Shim YH, Jung HY, Kim WH, Ro JY, Rhyu MG. CpG island methylation in premalignant stages of gastric carcinoma. Cancer Res 2001; 61: 2847–2851.PubMedGoogle Scholar
  44. Katayama M, Hirai S, Kamihagi K, et al. Soluble E-cadherin fragments increased in circulation of cancer patients. Br J Cancer 1994; 69: 580–585.PubMedGoogle Scholar
  45. Lewis FR, Mellinger JD, Hayashi A, Lorelli D, Monaghan KG, Carneiro F, Huntsman DG, Jackson CE, Caldas C. Prophylactic total gastrectomy for familial gastric cancer. Surgery 2001; 130: 612–617.CrossRefPubMedGoogle Scholar
  46. Machado JC, Soares P, Carneiro F, Rocha A, Beck S, Blin N, Berx G, Sobrinho-Simoes M. E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas. Lab Invest 1999; 79: 459–465.PubMedGoogle Scholar
  47. Matsuyoshi N, Tanaka T, Toda K, Okamoto H, Furukawa F, Imamura S. Soluble E-cadherin: a novel cutaneous disease marker. Br J Dermatol 1995; 132: 745–749.CrossRefPubMedGoogle Scholar
  48. Mayer B, Johnson JP, Leitl F, Jauch KW, Heiss MM, Schildberg FW, Birchmeier W, Funke J. E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Res 1993; 53: 1690–1695.PubMedGoogle Scholar
  49. Muta H, Noguchi M, Kanai Y, Ochiai A, Nawata H, Hirohashi S. E-cadherin gene mutation in signet ring cell carcinoma of the stomach. Jpn J Cancer Res 1996; 87: 843–848.PubMedGoogle Scholar
  50. Nass SJ, Herman JG, Gabrielson E, Iversen PW, Parl EF, Davidson NE, Graff JR. Aberrant methylation of the estrogen receptor and E-cadherin 5′ CpG islands increases with malignant progression in human breast cancer. Cancer Res 2000; 60: 4346–4348.PubMedGoogle Scholar
  51. Noe V, Fingleton B, Jacobs K, Crawford HC, Vermeulen S, Steelant W, Bruyneel E, Matrisian LM, Mareel M. Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. J Cell Sci 2001; 114: 111–118.PubMedGoogle Scholar
  52. Oliveira C, Bordin MC, Grehan N, Huntsman D, Suriano G, Machado JC, Kiviluoto T, Aaltonen L, Jackson CE, Seruca R, Caldas C. Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred. Hum Mutat 2002; 19: 510–517.CrossRefPubMedGoogle Scholar
  53. Perez-Moreno MA, Locascio A, Rodrigo I, Dhondt G, Portillo F, Nieto MA, Cano A. A new role for E12/E47 in the repression of E-cadherin expression and epithelial-mesenchymal transitions. J Biol Chem 2001;276:27424–27431.CrossRefPubMedGoogle Scholar
  54. Perry I, Tselepis C, Hoyland J, Iqbal TH, Scott D, Sanders SA, Cooper BT, Jankowski JA. Reduced cadherin/catenin complex expression in celiac disease can be reproduced in vitro by cytokine stimulation. Lab Invest 1999; 79: 1489–1499.PubMedGoogle Scholar
  55. Pittard AJ, Banks RE, Galley HF, et al. Soluble E-cadherin concentrations in patients with systemic inflammatory response syndrome and multiorgan dysfunction syndrome. Br J Anaesth 1996; 76: 629–631.PubMedGoogle Scholar
  56. Polakis P. Wnt signaling and cancer. Genes Dev 2000; 14: 1837–1851.PubMedGoogle Scholar
  57. Richards FM, McKee SA, Rajpar MH, et al. Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer. Hum Mol Genet 1999; 8: 607–610.CrossRefPubMedGoogle Scholar
  58. Risinger JI, Berchuck A, Kohler MF, Boyd J. Mutations of the E-cadherin gene in gynecologic cancers. Nat Genet 1994; 7: 98–102.CrossRefPubMedGoogle Scholar
  59. Salahshor S, Hou H, Diep CB, et al. A germline E-cadherin mutation in a family with gastric and colon cancer. Int J Mol Med 2001; 8: 439–443.PubMedGoogle Scholar
  60. Shimoyama Y, Hirohashi S. Expression of E- and P-cadherin in gastric carcinomas. Cancer Res 1991; 51: 2185–2192.PubMedGoogle Scholar
  61. Suzuki H, Itoh F, Toyota M, Kikuchi T, Kakiuchi H, Hinoda Y, Imai K. Distinct methylation pattern and microsatellite instability in sporadic gastric cancer. Int J Cancer 1999; 83: 309–313.CrossRefPubMedGoogle Scholar
  62. Takeichi M. Cadherins: a molecular family important in selective cell-cell adhesion. Annu Rev Biochem 1990; 59: 237–252.CrossRefPubMedGoogle Scholar
  63. Takeichi M. Morphogenetic roles of classic cadherins. Curr Opin Cell Biol 1995; 7: 619–627.CrossRefPubMedGoogle Scholar
  64. Tamura G, Sakata K, Nishizuka S, Maesawa C, Suzuki Y, Iwaya T, Terashima M, Saito K, Satodate R. Inactivation of the E-cadherin gene in primary gastric carcinomas and gastric carcinoma cell lines. Jpn J Cancer Res 1996; 87: 1153–1159.PubMedGoogle Scholar
  65. Tamura G, Sato K, Akiyama S, Tsuchiya T, Endoh Y, Usuba O, Kimura W, Nishizuka S, Motoyama T. Molecular characterization of undifferentiated-type gastric carcinoma. Lab Invest 2001; 81: 593–598.PubMedGoogle Scholar
  66. Tamura G, Yin J, Wang S, Fleisher AS, Zou T, Abraham JM, Kong D, Smolinski KN, Wilson KT, James SP, Silverberg SG, Nishizuka S, Terashima M, Motoyama T, Meltzer SJ. E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas. J Natl Cancer Inst 2000; 92: 569–573.CrossRefPubMedGoogle Scholar
  67. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA 1999; 96: 8681–8686.CrossRefPubMedGoogle Scholar
  68. Vleminckx K, Vakaet L Jr, Mareel M, et al. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 1991; 66: 107–119.CrossRefPubMedGoogle Scholar
  69. Vos CBJ, Cleton-Jansen AM, Berx G, De Leeuw WJF, Ter Haar NT, Van Roy F, Cornelisse CJ, Peters JL, Van de Vijver M.J. E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Br J Cancer 1997; 76: 1131–1133.PubMedGoogle Scholar
  70. Waki T, Tamura G, Tsuchiya T, Sato K, Nishizuka S, Motoyama T. Promoter methylation status of E-cadherin, hMLH1, and p16 genes in nonneoplastic gastric epithelia. Am J Pathol 2002; 161: 399–403.PubMedGoogle Scholar
  71. Wijnhoven BP, Dinjens WN, Pignatelli M. E-cadherin-catenin cell-cell adhesion complex and human cancer. Br J Surg 2000; 87: 992–1005.CrossRefPubMedGoogle Scholar
  72. Yagi T, Takeichi M. Cadherin superfamily genes: functions, genomic organization and neurologic diversity. Genes Dev 2000; 14: 1169–1180.PubMedGoogle Scholar

Copyright information

© Springer Science + Business Media, LLC 2009

Authors and Affiliations

  • Annie On On Chan
    • 1
  • Benjamin Chun-Yu Wong
    • 1
  1. 1.Department of MedicineUnviersity of Hong KongHong Kong

Personalised recommendations